Can Lerinlomab potentially work on Hepatitis B?
Post# of 148187
Vir is IPOing soon, and already funded around $360M in research. We could potentially kick their butt.
If so, someone can with more medial details, bring NP up to speed. If it take $20k to verify, and move to Phase 2.
https://www.bizjournals.com/sanfrancisco/news...yptr=yahoo